# Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax

> **NCT01127880** · PHASE2,PHASE3 · COMPLETED · sponsor: **St. Luke's Hospital, Pennsylvania** · enrollment: 50 (actual)

## Conditions studied

- Hemopneumothorax
- Pneumothorax

## Interventions

- **DRUG:** Ancef or Clindamycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01127880
- **Lead sponsor:** St. Luke's Hospital, Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01127880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01127880, "Role of Antibiotics to Reduce Infectious Complications in Tube Thoracotomy Management of Traumatic Hemopneumothorax". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01127880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*